Can TSH level and premenstrual spotting constitute a non-invasive marker for the diagnosis of endometriosis?

BMC Women's Health

Table 1 Baseline characteristics of patients included in the study, endometriosis group (EG) vs. control group (CG)

Characteristics	EG (n = 107)	CG (n = 60)	P value^f
Age^a	35.34 ± 3.48(107), median = 35	35.47 ± 4.62 (60), median = 36	> 0.05
rASRM endometriosis score (n)
1	27
2	40
3	28
4	12
Smoker^b
Yes	16% (17)	17% (10)	> 0.05
Menstrual cycle length^a	28.27 ± 2.23 (97) median = 28	28.18 ± 2.10 (48) median = 28	> 0.05
Pregnancies^c	30% (32)	42% (25)	> 0.05
Life births^d	9% (10)	22% (13)	< 0.05
Abortions^e	22% (24)	33% (20)	> 0.05

^aData are presented as mean values ± standard deviations (absolute incidence), median
^bData are presented as percentage (absolute incidence)
^cNumber of patients who were pregnant before starting infertility treatment
^dNumber of patients who gave birth before starting infertility treatment
^eNumber of patients who had miscarriage(s) before starting infertility treatment
^fA P value < 0.05 was considered significant

ISSN: 1472-6874